Stem Cells Explained Simply
Written by Viktor Jonas · Reading time about 6 minutes
A stem cell can do two things: renew itself and turn into specialised cells. From it arises skin, blood or nerve, depending on which signals it receives.
Differentiation — specialisation into a particular cell type.
Totipotent — can form a complete organism; only the fertilised egg cell and the first stages of division.
Pluripotent — can form all cell types of the body, but not a whole organism.
Multipotent — can form several related cell types, for example all blood cells.
iPS cells — induced pluripotent stem cells, reprogrammed from body cells.
| Level | Where found | Can form |
|---|---|---|
| totipotent | zygote, first divisions | the whole organism including the placenta |
| pluripotent | early blastocyst, iPS cells | all over 200 cell types of the body |
| multipotent | bone marrow, skin, gut | one tissue family, e.g. all blood cells |
| unipotent | e.g. precursors of sperm cells | exactly one cell type |
Why reprogramming was so important
For a long time, differentiation was considered a one-way street. In 2006, Shinya Yamanaka showed that skin cells can be put back into a pluripotent state with just a few factors: the iPS cells. This makes it possible to obtain a patient's own cells without using up embryos. Yamanaka received the 2012 Nobel Prize in Medicine for this.
💬 Mia asks Grandpa Theo
Why is this topic so controversial?
Because embryos used to be used up to obtain embryonic stem cells. iPS cells defuse exactly this conflict, because they come from ordinary skin.
Can you rebuild any organ with them?
Not yet. Individual tissues, yes, but a complete organ with blood vessels and nerves is research, not treatment.
What is already routine today
Stem cell transplantation for leukaemia has been established for decades: blood-forming stem cells from the bone marrow or from the blood of a donor rebuild the entire blood system. Procedures for treating severe damage to the cornea of the eye are also recognised. Everything beyond that, such as heart, spinal cord and pancreas, is in clinical trials.
Common mistakes
- Treating totipotent and pluripotent as the same
- Only totipotent cells can form a whole organism including the placenta.
- Confusing stem cells with clones
- These are two different procedures.
- “Stem cells cure everything.”
- Blood cancer and a few eye diseases are established; the rest is research.
- Thinking adults have no stem cells
- Bone marrow, skin and gut renew themselves throughout life from multipotent stem cells.
Explain the difference between pluripotent and multipotent stem cells, and explain why iPS cells are ethically less controversial than embryonic ones.
Show solution
Pluripotent cells can form all of the more than 200 cell types of the body, multipotent cells only the types of one tissue family. A blood-forming stem cell produces red and white blood cells and platelets, but never a nerve cell.
iPS cells arise from ordinary body cells, such as skin, which are reprogrammed by introduced factors. No embryo is used up. In addition, they come from the patient, so the immune system does not reject them. The ethical objection to destroying embryos therefore falls away completely.
Where stem cells come from
Stem cells are not a uniform material from the lab but come from very different sources, and what one can do with them depends on that.
Embryonic stem cells come from embryos a few days old and are pluripotent, so they can form all cell types of the body. This is exactly where the ethical debate lies. Adult stem cells, by contrast, sit in every adult body, but are only multipotent: blood-forming stem cells in the bone marrow supply all blood cell types, but no nerve cells. Umbilical cord blood also contains blood-forming stem cells and can be frozen after birth. And since 2006 there have been induced pluripotent stem cells, iPS for short: ordinary body cells, for example from the skin, which are set back to an embryonic state by introducing a few control genes. They avoid the ethical question entirely, because no embryo is needed.
Stem cell transplantation for leukaemia is the oldest established application and shows well what this looks like in practice. First a donor must be found whose tissue characteristics match the recipient: the more similar they are, the lower the risk that the new immune cells attack the recipient's body. In about 80 percent of cases today, the cells are no longer taken from the pelvic bone but from the blood: for a few days the donor receives a drug that flushes stem cells out of the bone marrow into the blood, and these are then filtered out in a procedure similar to a blood donation. In the recipient, the diseased bone marrow is destroyed beforehand by radiation or chemotherapy. The transferred stem cells then find their own way into the bone marrow and build up a completely new blood-forming system there. After a few weeks, the recipient carries the blood group of the donor.
For school, one clean distinction is especially worthwhile: the origin of a stem cell (embryonic, adult or induced) is something different from its potential (totipotent, pluripotent or multipotent). The two often coincide, but not always, and iPS cells are exactly the case where they come apart.
How a stem cell decides what to become
A stem cell does not choose its future alone. Its surroundings send signals, such as chemical messengers from neighbouring cells and the stiffness and composition of the tissue it sits in, and these signals switch certain genes on and others off. All the cells of the body carry the same DNA; a nerve cell and a muscle cell differ because they read different parts of it. Differentiation is therefore a story of gene activity and not of lost or added genes, and that is exactly why Yamanaka's factors could reverse it: they reset which genes are active. When a stem cell divides, it can produce two new stem cells, two specialised cells, or one of each. Healthy tissue keeps this balance: too few new stem cells and the tissue wears out, too many and there is a risk of uncontrolled growth.
Around 330 billion cells are replaced in the human body every day. This is possible only because a supply of stem cells is ready in almost every tissue.
← Back to overview